High RARRES1 expression was correlated with poor median survival of patients with inflammatory BRCA (34), while cell proliferation and tumor growth assays showed that RARRES1 was a tumor suppressor in triple-negative BRCA cell lines (35). This evidence concerns the gene RARRES1 and neoplasm.